What does Oriolus do?
ORIOLUS specializes in innovative solutions in the field of biotechnology and life sciences. The company focuses on developing advanced technologies for research and diagnostics. ORIOLUS aims to improve health outcomes through its cutting-edge products and services.
- Activities
- Signals
-
Poor liquidityPoor liquidity 0.29
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 5KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.45MStrong equity provides a buffer against setbacks.
Low riskLow risk 60.8%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 5KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 5KPositive EBITDA: operating activities are profitable.
- Shareholders
- Sdd Consult 50%, Lexius Management 12,5%
- Investments
- Etalutil 82%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
6K
|
€
3K
|
€
-21K
|
€
57K
|
|
|
€
5K
|
€
600
|
€
-22K
|
€
57K
|
|
|
€
5K
|
€
205
|
€
-25K
|
€
53K
|
|
|
€
1.45M
|
€
1.45M
|
€
1.45M
|
€
1.47M
|
|
|
60.83%
|
61.24%
|
58.44%
|
62.38%
|
|
|
€
935K
|
€
916K
|
€
1.03M
|
€
888K
|
|
|
€
2K
|
€
23
|
€
764
|
€
1K
|
Publications 13
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Ontslagen - Benoemingen 10/01/2024
- Ontslagen - Benoemingen 17/12/2018
- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 04/01/2018
- Me. - Jaarrekening 31.12.2015, Ggk 30.06.2016, Ngl 12.07.2016 16310-0059-014 20/07/2016
- Me. - Jaarrekening 31.12.2014, Ggk 30.06.2015, Ngl 23.07.2015 15343-0267-014 29/07/2015
Frequently asked questions
Answers to the most common questions about Oriolus, based on official government data and the filed annual accounts.
What is the VAT number of Oriolus?
The VAT number of Oriolus is BE0890.584.813.
When was Oriolus established?
Oriolus was founded in 27-06-2007.
What is the official address of Oriolus?
The official address of Oriolus is Vaartdijk(Til) 24 Haacht 3150.
What is the legal form of Oriolus?
The juridical form of Oriolus is Private limited company (BV/SRL).
What is the annual revenue of Oriolus?
The 2025 accounts of Oriolus do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Oriolus do?
ORIOLUS specializes in innovative solutions in the field of biotechnology and life sciences. The company focuses on developing advanced technologies for research and diagnostics. ORIOLUS aims to improve health outcomes through its cutting-edge products and services.
Is Oriolus a reliable company?
Oriolus is a registered Rechtspersoon with company number 0890.584.813 and can be verified through the official CBE database.
What is the credit limit of Oriolus?
The estimated credit limit of Oriolus is €66,623.
Is Oriolus still active?
Oriolus currently has the status "Normal situation" and is active.